Morgan Stanley Highlights-----Pimavanserin, the new Viagra | ACAD Message Board Posts

ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  15616 of 15693  at  9/11/2019 12:37:55 PM  by

gains_52


 In response to msg 15614 by  good_investor93
view thread

Re: Morgan Stanley Highlights-----Pimavanserin, the new Viagra

Serendipity!

"Big disappointment in SSRI therapy in depression is sexual dysfunction. In Nuplazid phase 2 trial, improvement was seen in sexual function. CEO: what was seen in depression trial in efficacy is exactly what many physicians say they want in new therapies."


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 13     Views: 429
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
15621 Re: Morgan Stanley Highlights-----Pimavanserin, the new Viagra Biotech2050 1 9/12/2019 1:37:17 AM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...